Labelling and Medical Schools - Pharmacist Digest

Q&A: Why drafting new rules on ultra-processed foods is so hard

STAT

OCTOBER 29, 2024

Whole grain cereal and breads also qualify for the label, as do yogurts and some other dairy desserts. Processed meats, as their name would suggest, also belong in this category. But ultra-processed foods are not all the same.

Medical Schools

Medical Schools Packaging Labelling Hospitals

FDA AdCom votes in favour of Lundbeck’s/Otsuka’s Rexulti in AAD

Pharmaceutical Technology

APRIL 17, 2023

The current unmet need, the benefit of treatment with Rexulti, and a reasonable safety profile persuaded Dr. Merit Cudkowicz, Julieanne Dorn professor of neurology at Harvard University’s Medical School, to give a positive vote. Rexulti is an atypical antipsychotic.

Medical Schools

Medical Schools Labelling Communication

Over-the-Counter Choices Pharmacist Role and Resources

FADIC

JULY 14, 2024

OTC drugs come in various forms, including tablets, capsules, creams, and liquids, and are generally labeled with clear instructions on proper usage and dosage. The FDA’s website provides a wealth of information on OTC drugs, including product labels, warnings, and recalls.

Adverse Reactions

Adverse Reactions Dosage Mayo Clinic Medical Schools

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

SEPTEMBER 16, 2022

He has been a research fellow at Harvard Medical School, Boston, the University of California, San Francisco, and University Spital Zürich, Switzerland, where his research focused on atopic dermatitis and the complexity of the skin barrier.

Medical Schools

Medical Schools Hospitals Dosage Labelling

Biogen and Eisai’s Alzheimer’s drug secures support in closely watched AdCom

Pharmaceutical Technology

JUNE 12, 2023

The evidence for clinical benefit was “very clear”, said Dr. Merit Cudkowicz, Julieanne Dorn professor of neurology at Harvard University’s Medical School. Robert Alexander, research professor at the University of Arizona’s College of Medicine, who voted in favour of Leqembi at the 9 June meeting.

Medical Schools

Medical Schools Labelling Drug Development

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

SEPTEMBER 2, 2022

She also has been conducting fundamental research as an academic in several universities, with her last academic position held at Harvard Medical School. She holds a MSc in Public Health and a PhD in Biophysics and Molecular Biology. About the author. Hannah Balfour is the Science Writer for European Pharmaceutical Review. References.

Adverse Reactions

Adverse Reactions Documentation Medical Schools Packaging

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

APRIL 24, 2023

In an email to this news service, João Conde, PhD, professor at NOVA Medical School, Universidade NOVA de Lisboa, said advances like the mRNA vaccines serve as a testament to the breakthroughs made by science over decades of research at the junction of genetics and nanomedicine.

Vaccines

Vaccines Immunity Immunization Medical Schools

Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS

Express Pharma

JANUARY 19, 2025

This study consists of a 36-week treatment phase, followed by a 16-week open-label extension. This study will enrol 210 ALS patients and study doses of 50 mg and 75 mg Usnoflast versus placebo.

Clinical Pharmacology

Clinical Pharmacology Labelling Medical Schools Drug Development

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

JANUARY 8, 2021

I DID NOT consent to receive an off-label drug with NO evidence of benefit with a single dose. The British Medical Association (BMA) also blasted the decision as “unreasonable and totally unfair”. Just received this email cancelling my 2nd dose of the Pfizer vaccine. On the basis of UK government guidance yesterday.

Vaccines

Vaccines Immunity Immunization Medical Schools

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

pharmaphorum

JANUARY 8, 2021

I DID NOT consent to receive an off-label drug with NO evidence of benefit with a single dose. The British Medical Association (BMA) also blasted the decision as “unreasonable and totally unfair”. Just received this email cancelling my 2nd dose of the Pfizer vaccine. On the basis of UK government guidance yesterday.

Vaccines

Vaccines Immunity Immunization Medical Schools

Twenty Women Leaders In Healthcare Industry

PharmaShots

MARCH 9, 2023

She developed various mobile technologies and pioneered early electronic labels including NFC tags, which helped Thin Film Electronics win the Wall Street Innovation Award and the Global Technology Award. Education: Laura holds a Doctor of Medicine degree from the prestigious Harvard Medical School.

Clinical Pharmacology

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies

Q&A: Why drafting new rules on ultra-processed foods is so hard

STAT

OCTOBER 29, 2024

Whole grain cereal and breads also qualify for the label, as do yogurts and some other dairy desserts. Processed meats, as their name would suggest, also belong in this category. But ultra-processed foods are not all the same.

Medical Schools

Medical Schools Packaging Labelling Hospitals

STAT+: FDA authorizes many AI devices for use in kids. Are they validated in a pediatric population?

STAT

DECEMBER 16, 2024

But with little financial incentive for companies to develop kid-specific treatments, pediatricians are often left to use adult medicines and medical devices off-label for their patients — or none at all. Children aren’t just little adults, goes the saying in pediatrics.

Medical Schools

Medical Schools Labelling Documentation Hospitals

Anatomy of a ‘correlate of protection’ for T-cell vaccines

European Pharmaceutical Review

JUNE 28, 2022

Each of the recovered class I peptides can be assigned to either the self-repertoire or matched to sequences unique to the infecting virus (labelled ‘Emergex’ in the figure). Rademacher , MD, PhD is Emeritus Professor of Molecular Medicine at University College London Medical School and CEO of Emergex Vaccines. About the author.

Vaccines

Vaccines Immunity Immunization Medical Schools

How to Lose Weight With Hashimoto’s

The Thyroid Pharmacist

NOVEMBER 29, 2024

As a pharmacist, I am amazed that the simple strategies that I have found to work nine times out of ten for symptoms like anxiety, fatigue, muscle wasting, and hair loss, are not widely taught in medical schools. I have seen people gain 100+ pounds on this medication. You can actually overcome fatigue in three days!

Health and Personal Care Stores

Health and Personal Care Stores Diabetes Immunity Immunization

Pharmacist Digest

Q&A: Why drafting new rules on ultra-processed foods is so hard

FDA AdCom votes in favour of Lundbeck’s/Otsuka’s Rexulti in AAD

Trending Sources

Over-the-Counter Choices Pharmacist Role and Resources

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

Biogen and Eisai’s Alzheimer’s drug secures support in closely watched AdCom

Pharmacovigilance deep dive: risk minimisation measures

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

Resourceful or risky? The UK’s controversial COVID-19 vaccine strategy

Twenty Women Leaders In Healthcare Industry

Q&A: Why drafting new rules on ultra-processed foods is so hard

STAT+: FDA authorizes many AI devices for use in kids. Are they validated in a pediatric population?

Anatomy of a ‘correlate of protection’ for T-cell vaccines

How to Lose Weight With Hashimoto’s

Stay Connected